Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
1 clinical trials · Condition
◉ Watch Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
| Record | Firm | Date |
|---|---|---|
| Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation (NCT06501625) | Institut de Recherches Internationales Servier | 2024-12-16 |
Track Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.